137 related articles for article (PubMed ID: 176937)
1. In vitro susceptibility of varicella zoster virus to adenine arabinoside and hypoxanthine arabinoside.
Bryson YJ; Connor JD
Antimicrob Agents Chemother; 1976 Mar; 9(3):540-3. PubMed ID: 176937
[TBL] [Abstract][Full Text] [Related]
2. Antiherpesvirus activity in human sera and urines after administration of adenine arabinoside: in vitro and in vivo synergy of adenine arabinoside and arabinosylhypoxanthine in combination.
Champney KJ; Lauter CB; Bailey EJ; Lerner AM
J Clin Invest; 1978 Dec; 62(6):1142-53. PubMed ID: 219024
[TBL] [Abstract][Full Text] [Related]
3. Effects of adenine arabinoside on cellular immune mechanisms in humans.
Steele RW; Chapa IA; Vincent MM; Hensen SA; Keeney RE
Antimicrob Agents Chemother; 1975 Feb; 7(2):203-7. PubMed ID: 1137371
[TBL] [Abstract][Full Text] [Related]
4. Metabolism and pharmacokinetics of the anti-varicella-zoster virus agent 6-dimethylaminopurine arabinoside.
Lambe CU; Resetar A; Spector T; Koszalka GW; Nelson DJ
Antimicrob Agents Chemother; 1992 Feb; 36(2):353-60. PubMed ID: 1318679
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the antiviral effects of 5-methoxymethyl-deoxyuridine with 5-iododeoxyuridine, cytosine arabinoside, and adenine arabinoside.
Babiuk LA; Meldrum B; Gupta VS; Rouse BT
Antimicrob Agents Chemother; 1975 Dec; 8(6):643-50. PubMed ID: 1239978
[TBL] [Abstract][Full Text] [Related]
6. 6-Methoxypurine arabinoside as a selective and potent inhibitor of varicella-zoster virus.
Averett DR; Koszalka GW; Fyfe JA; Roberts GB; Purifoy DJ; Krenitsky TA
Antimicrob Agents Chemother; 1991 May; 35(5):851-7. PubMed ID: 1649571
[TBL] [Abstract][Full Text] [Related]
7. Determination of plaque inhibitory activity of adenine arabinoside (9-beta-D-arabinofuranosyladenine) for herpesviruses using an adenosine deaminase inhibitor.
Bryson Y; Connor JD; Sweetman L; Carey S; Stuckey MA; Buchanan R
Antimicrob Agents Chemother; 1974 Jul; 6(1):98-101. PubMed ID: 15828177
[TBL] [Abstract][Full Text] [Related]
8. Anti-herpes activity of adenine arabinoside monophosphate.
Trobe JD; Centifanto Y; Zam ZS; Varnell E; Kaufman HE
Invest Ophthalmol; 1976 Mar; 15(3):196-9. PubMed ID: 1254407
[TBL] [Abstract][Full Text] [Related]
9. 6-N-substituted derivatives of adenine arabinoside as selective inhibitors of varicella-zoster virus.
Koszalka GW; Averett DR; Fyfe JA; Roberts GB; Spector T; Biron K; Krenitsky TA
Antimicrob Agents Chemother; 1991 Jul; 35(7):1437-43. PubMed ID: 1656862
[TBL] [Abstract][Full Text] [Related]
10. Effect of adenosine deaminase upon the antiviral activity in vitro of adenine arabinoside for vaccinia virus.
Connor JD; Sweetman L; Carey S; Stuckey MA; Buchanan R
Antimicrob Agents Chemother; 1974 Nov; 6(5):630-6. PubMed ID: 15825318
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the effects of cytosine arabinoside and adenine arabinoside on some aspects of brain growth and development in the rat.
Adlard BP; Dobbing J; Sands J
Br J Pharmacol; 1975 May; 54(1):33-9. PubMed ID: 1169994
[TBL] [Abstract][Full Text] [Related]
12. Microbiologic assays and neurological toxicity during use of adenine arabinoside in humans.
Lauter CB; Bailey EJ; Lerner AM
J Infect Dis; 1976 Jul; 134(1):75-9. PubMed ID: 181499
[TBL] [Abstract][Full Text] [Related]
13. 9-{[3-fluoro-2-(hydroxymethyl)cyclopropylidene]methyl}adenines and -guanines. Synthesis and antiviral activity of all stereoisomers1.
Zhou S; Kern ER; Gullen E; Cheng YC; Drach JC; Tamiya S; Mitsuya H; Zemlicka J
J Med Chem; 2006 Oct; 49(20):6120-8. PubMed ID: 17004726
[TBL] [Abstract][Full Text] [Related]
14. Antiviral activity in the rabbit cornea of adenine arabinoside, Ara-A 5' monophosphate, and hypoxanthine arabinoside; and interactions with adenosine deaminase inhibitor.
Falcon MG; Jones BR
J Gen Virol; 1977 Jul; 36(1):199-202. PubMed ID: 196039
[TBL] [Abstract][Full Text] [Related]
15. Effects of cytosine arabinoside, adenine arabinoside, and 6-azauridine on rabies virus in vitro and in vivo.
Harmon MW; Janis B
J Infect Dis; 1976 Jan; 133(1):7-13. PubMed ID: 1245759
[TBL] [Abstract][Full Text] [Related]
16. Ineffectiveness of adenine arabinoside and adenine arabinoside 5'-monophosphate in simian varicella infection.
Soike KF; Felsenfeld AD; Gibson S; Gerone PJ
Antimicrob Agents Chemother; 1980 Jul; 18(1):142-7. PubMed ID: 6158291
[TBL] [Abstract][Full Text] [Related]
17. Synergistic inhibition of herpesvirus replication by docosanol and antiviral nucleoside analogs.
Marcelletti JF
Antiviral Res; 2002 Nov; 56(2):153-66. PubMed ID: 12367721
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory and lethal concentrations of 9-beta-D-arabinofuranosyladenine and its hypoxanthine-derivative versus herpes simplex virus, type 1.
Williams BB; Bailey EJ; Lerner AM
J Lab Clin Med; 1977 Apr; 89(4):687-91. PubMed ID: 191546
[TBL] [Abstract][Full Text] [Related]
19. Synergistic antiviral effects of antiherpes compounds and human leukocyte interferon on varicella-zoster virus in vitro.
Baba M; Ito M; Shigeta S; De Clercq E
Antimicrob Agents Chemother; 1984 Apr; 25(4):515-7. PubMed ID: 6329083
[TBL] [Abstract][Full Text] [Related]
20. Combined antiviral effects of interferon, adenine, arabinoside, hypoxanthine arabinoside, and adenine arabinoside-5'-monophosphate in human fibroblast cultures.
Bryson YJ; Kronenberg LH
Antimicrob Agents Chemother; 1977 Feb; 11(2):299-306. PubMed ID: 848937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
